Cargando…

Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study

BACKGROUND: Asthma is a chronic inflammatory disease of the airways that causes recurring episodes of wheezing, breathlessness, chest tightness and coughing. Inhaled drugs on a daily basis are the cornerstone of asthma treatment, therefore, patient adherence is very important. METHODS: We performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Exarchos, Konstantinos P., Rovina, Nikoletta, Krommidas, George, Latsios, Dimitrios, Gogali, Athena, Kostikas, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238005/ https://www.ncbi.nlm.nih.gov/pubmed/35761234 http://dx.doi.org/10.1186/s12890-022-02049-0

Ejemplares similares

Correction to: Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study
por: Exarchos, Konstantinos P., et al.
Publicado: (2022)

The Diagnostic Role of Uric Acid to Creatinine Ratio for the Identification of Patients with Adverse Pulmonary Embolism Outcomes
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

Recent Advances of Artificial Intelligence Applications in Interstitial Lung Diseases
por: Exarchos, Konstantinos P., et al.
Publicado: (2023)

Asthma and Tobacco Smoking
por: Bellou, Vanesa, et al.
Publicado: (2022)

Identification and treatment of T2-low asthma in the era of biologics
por: Kyriakopoulos, Chris, et al.
Publicado: (2021)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

Recurrent bilateral lung infiltrates in a patient with ulcerative colitis
por: Assioura, Antonia, et al.
Publicado: (2022)

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler(®) Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study
por: Steiropoulos, Paschalis, et al.
Publicado: (2021)

Validation of the portable Bluetooth® Air Next spirometer in patients with different respiratory diseases
por: Exarchos, Konstantinos P., et al.
Publicado: (2020)

Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults
por: Boulet, Louis-Philippe, et al.
Publicado: (2010)

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations
por: Kuna, P, et al.
Publicado: (2007)

Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms
por: Souma, Ryosuke, et al.
Publicado: (2018)

Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
por: Bateman, ED, et al.
Publicado: (2006)

Corticosteroids in COVID-19: one size does not fit all
por: Gogali, Athena, et al.
Publicado: (2021)

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification
por: Kostikas, Konstantinos, et al.
Publicado: (2023)

A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma
por: Virchow, J. Christian, et al.
Publicado: (2016)

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
por: Huynh, Peter N, et al.
Publicado: (2010)

Long-term safety of budesonide/formoterol for the treatment of elderly patients with bronchial asthma
por: KAGOHASHI, KATSUNORI, et al.
Publicado: (2014)

Comparative Efficacy of Budesonide/Formoterol with Budesonide, Formoterol or Placebo for Stable Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Tang, Bin, et al.
Publicado: (2019)

Correction to: A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler(®) to Budesonide/Formoterol Easyhaler(®)
por: Syk, Jörgen, et al.
Publicado: (2019)

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
por: Arun, Jenish J, et al.
Publicado: (2012)

Hypercoagulable State in COPD-A Comprehensive Literature Review
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)

A direct adverse effect of smoking
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Comparison of Aerosol Formulations of Formoterol Fumarate and Budesonide
por: Nirale, N. M., et al.
Publicado: (2011)

Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction
por: Lazarinis, Nikolaos, et al.
Publicado: (2014)

Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients
por: Back, Hyun-moon, et al.
Publicado: (2020)

A Pilot Randomized Trial of As-Needed Budesonide-Formoterol for Stepping Down Controller Treatment in Moderate Asthma with Complete Remission
por: Nakwan, Narongwit, et al.
Publicado: (2022)

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study
por: Price, David B., et al.
Publicado: (2018)

Budesonide/formoterol combination in COPD: a US perspective
por: Sharafkhaneh, Amir, et al.
Publicado: (2010)

Tolerability of budesonide/formoterol in patients of Kazakhstan rural regions
por: Nurpeissov, Tair, et al.
Publicado: (2015)

Correction to: Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

A 68-year-old man with haemoptysis and extensive ipsilateral lung infiltrates
por: Kyriakopoulos, Chris, et al.
Publicado: (2021)

Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
por: Bateman, Eric D, et al.
Publicado: (2011)

A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management
por: Louis, R, et al.
Publicado: (2009)

Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate
por: Liang, Yingjian, et al.
Publicado: (2021)

Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
por: FitzGerald, J. Mark, et al.
Publicado: (2021)

Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma
por: Yi, Fang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_af0371cfrqun4rg4j13d7bovic